| Year |
Citation |
Score |
| 2020 |
Ham A, Kim MH, Kim GM, Kim JH, Kim JY, Park HS, Park S, Cho YU, Park BW, Kim SI, Sohn J. Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer. Breast Cancer Research and Treatment. PMID 32661666 DOI: 10.1007/s10549-020-05796-y |
0.325 |
|
| 2018 |
Lee HW, Choi B, Kang HN, Kim H, Min A, Cha M, Ryu JY, Park S, Sohn J, Shin K, Yun MR, Han JY, Shon MJ, Jeong C, Chung J, et al. Profiling of protein-protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors. Nature Biomedical Engineering. 2: 239-253. PMID 30936439 DOI: 10.1038/S41551-018-0212-3 |
0.318 |
|
| 2018 |
Nam JG, Park S, Hwang EJ, Lee JH, Jin KN, Lim KY, Vu TH, Sohn JH, Hwang S, Goo JM, Park CM. Development and Validation of Deep Learning-based Automatic Detection Algorithm for Malignant Pulmonary Nodules on Chest Radiographs. Radiology. 180237. PMID 30251934 DOI: 10.1148/radiol.2018180237 |
0.301 |
|
| 2018 |
Kim JD, Cho EJ, Ahn C, Park SK, Choi JY, Lee HC, Kim DY, Choi MS, Wang HJ, Kim IH, Yeon JE, Seo YS, Tak WY, Kim MY, Lee HJ, ... ... Park SH, et al. A Novel Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. Hepatology (Baltimore, Md.). PMID 30194739 DOI: 10.1002/hep.30262 |
0.304 |
|
| 2018 |
Kim HJ, Lee MH, Lee JE, Park S, Lee ES, Kang YJ, Shin HN, Kim SI, Lee JH, Im SA, Ahn SH, Lee KS, Sohn J, Kim S, Nam SJ, et al. Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy. Clinical Breast Cancer. PMID 29843988 DOI: 10.1016/j.clbc.2018.04.008 |
0.333 |
|
| 2017 |
Hong N, Yoon HG, Seo DH, Park S, Kim SI, Sohn JH, Rhee Y. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study. European Journal of Cancer (Oxford, England : 1990). 82: 103-114. PMID 28651157 DOI: 10.1016/j.ejca.2017.05.002 |
0.34 |
|
| 2017 |
Baek AR, Kim HK, Park S, Lee GH, Kang HJ, Jung JC, Park JS, Ryeom HK, Kim TJ, Chang Y. A Gadolinium Complex of 1,4,7,10-Tetraazacyclododecane-1,4,7-trisacetic acid (DO3A)-Ethoxybenzyl (EOB) Conjugate as a New Macrocyclic Hepatobiliary MRI Contrast Agent. Journal of Medicinal Chemistry. PMID 28530407 DOI: 10.1021/acs.jmedchem.7b00060 |
0.397 |
|
| 2017 |
Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, Kim SI, Kim D, Sohn J. Chemotherapy-induced irreversible alopecia in early breast cancer patients. Breast Cancer Research and Treatment. PMID 28324267 DOI: 10.1007/s10549-017-4204-x |
0.351 |
|
| 2017 |
Park HS, Sohn J, Kim SI, Park S, Park HS, Gho SG, Chung HC, Paik S, Kim GM. Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer. Breast Cancer Research and Treatment. PMID 28243895 DOI: 10.1007/s10549-017-4175-y |
0.35 |
|
| 2017 |
Park HS, Han HJ, Lee S, Kim GM, Park S, Choi YA, Lee JD, Kim GM, Sohn J, Kim SI. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR. Yonsei Medical Journal. 58: 19-26. PMID 27873491 DOI: 10.3349/ymj.2017.58.1.19 |
0.339 |
|
| 2011 |
Lim S, Lee S, Park B, Kim SI, Park S, Kim J, Choi HJ, Sohn JH. Prolonged clinical benefit with the maintenance hormone therapy in patients with metastatic breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e11051. PMID 28023422 DOI: 10.1200/jco.2011.29.15_suppl.e11051 |
0.35 |
|
| Show low-probability matches. |